• If you are wondering whether Maximus shares are now offering value or still look fully priced, the recent share performance gives you some useful clues.
• The stock last closed at US$69.11, with returns of 2.2% over 1 year but declines of 6.3% over 7 days, 7.5% over 30 days, and 20.1% year to date.
• Recent headlines have focused on Maximus as a key contractor in government services, including ongoing work in areas such as health and human services administration. This keeps attention on the stability of its contract driven model. At the same time, market commentary has highlighted how contract renewal cycles and policy decisions can influence expectations. This helps frame the mixed share price performance over different time frames.
• On Simply Wall St's valuation checks, Maximus has a valuation score of 5 out of 6, and the sections that follow will walk through what that means using different valuation methods, before finishing with a broader way to think about value that goes beyond a single score.

Approach 1: Maximus Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model looks at the cash Maximus is expected to generate in the future and then discounts those projected cash flows back to today to estimate what the business might be worth right now.

Maximus recently reported last twelve month Free Cash Flow of about $170.5 million. The Simply Wall St model uses a 2 Stage Free Cash Flow to Equity approach, with analyst input where available and then extrapolations beyond that. For example, projected Free Cash Flow for 2026 is $491.1 million, and for 2035 it is $570.1 million, all in dollars. These ten year projections are then discounted back to today using the DCF method.

On this basis, the estimated intrinsic value for Maximus is about $166.95 per share. Compared with the recent share price of US$69.11, the DCF output suggests that the shares trade at a 58.6% discount under this specific cash flow model.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Maximus is undervalued by 58.6%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.

Approach 2: Maximus Price vs Earnings

For a profitable company, the P/E ratio is a useful shorthand for how much investors are paying for each dollar of earnings. It links directly to what you, as a shareholder, are effectively paying for the business today based on its current profit.

What counts as a normal or fair P/E often reflects how the market views a company’s growth potential and risk. Higher growth or lower perceived risk can support a higher P/E, while slower growth or higher risk tends to justify a lower P/E.

Maximus currently trades on a P/E of 10.14x. This is below the Professional Services industry average P/E of about 19.14x and also below the wider peer group average of 21.55x. Simply Wall St’s Fair Ratio for Maximus is 19.81x, which is the P/E level its model suggests based on factors such as earnings growth, industry, profit margins, market cap and company specific risks.

The Fair Ratio goes a step further than simple peer or industry comparisons because it adjusts for the company’s own characteristics rather than assuming all firms deserve the same multiple. Comparing Maximus’s current P/E of 10.14x with its Fair Ratio of 19.81x points to the shares trading below that modelled fair level.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Maximus Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach your story about Maximus to the numbers by linking a clear view of its business, your assumptions for future revenue, earnings and margins, and a Fair Value that you can compare with the current share price. These Narratives sit on the Community page, update automatically when fresh news or earnings arrive, and capture different viewpoints, such as a more cautious Fair Value around US$90 that focuses on contract and automation risks, or a more optimistic Fair Value around US$125 that leans on future defense and health contracts, so you can quickly see which story lines up with your own expectations.

Do you think there's more to the story for Maximus? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.